Advertisement
Visit TheBody.com for Patient Education
You are not currently logged in.
Login
or
Register
Sign up for free e-mail/fax newsletters!
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy
Antiretroviral Therapy
Acute Infection
Primary Care
Antiretrovirals
Assays (Diagnostic & Monitoring)
Guidelines
Initial Therapy
Pediatrics
Resistance
Salvage Therapy
Second/Third-Line Treatment
Structured Treatment Interruptions
Women & Pregnancy
More ...
Complications of HIV/HAART
Complications of HIV/HAART
Overview
Cardiovascular
Lipoatrophy
Gastrointestinal
Hepatitis
HPV & Cervical/Anal Cancer
Liver Complications
Malignancies
Mental Health
Metabolic
Neurocognitive
Renal Complications
Women-Specific
More ...
Research & Development
Research & Development
Overview
Antiretrovirals in Development
Conference Reports
HIV Genetics
HIV Immunology
More ...
Clinical Trials
Clinical Trials
Overview & News
U.S. Databases
U.S. Nationwide Studies
U.S. State-by-State Trial Listings
Databases Outside U.S.
Specific Trials Outside U.S.
More ...
Quality of Life & Patient Care
Quality of Life & Patient Care
Mental Health
E-Mail
Share
Failed Antiretrovirals
Overview
|
Capravirine
|
DAPD (Amdoxovir)
|
Lodenosine
|
T-1249
Show Archived (Historical) Articles
Overview
Failed Anti-HIV Drugs
(Regularly Updated)
From aidsmap.com
Capravirine
A Clinical Overview of Capravirine
(Regularly Updated)
To read PDF,
click here
.
From
U.S. National Institutes of Health
Pfizer Drops Development of Antiretroviral Capravirine, Citing Lack of Efficacy in Trials
(July 5, 2005)
In
Kaiser Daily HIV/AIDS Report
, from
Henry J. Kaiser Family Foundation
Othe Drugs
Incyte Halts Development of Promising New CCR5 Drug
(April 10, 2008)
From
Project Inform
GSK Discontinues Clinical Development of Investigational Protease Inhibitor Brecanavir (640385)
(December 18, 2006)
To read PDF,
click here
.
From GlaxoSmithKline
Development of DFC, an Investigational NRTI, Is Discontinued
(April 4, 2006)
From
The Body
E-Mail
Share
Advertisement